摘要
背景:发达国家和发展中国家心血管疾病仍然是最常见的死因,而代谢综合征和心肌缺血再灌注(I / R)损伤是导致心脏功能受损的常见危险因素。瞬态受体电位(TRP)通道是非选择性阳离子通道,其可以感觉从诸如拉伸等物理条件到包括辣椒素在内的化学物质的广泛刺激。 目的:多因素研究揭示了TRP通道在生理条件和各种疾病中的多功能作用,而TRP通道超家族的一些成员被证明参与心脏代谢疾病和心肌缺血再灌注损伤的病理生理学。在这里我们讨论TRP通道在心肌缺血再灌注和心脏代谢疾病中的作用及其在治疗这些疾病中的潜在用途。 结果:调节TRP通道有助于控制代谢综合征,如肥胖,糖尿病,高血压和动脉粥样硬化。本综述概述了我们目前关于代谢和心血管系统中TRP通道的生理功能的知识及其对心脏代谢疾病和I / R损伤的贡献。 结论:在这些发现的基础上,可以提出靶向新型TRP通道的治疗潜力,用于治疗心脏代谢疾病和I / R损伤。
关键词: 心脏代谢疾病,糖尿病,高血压,心肌缺血再灌注损伤,肥胖,瞬时受体电位通道
图形摘要
Current Drug Targets
Title:Targeting Transient Receptor Potential Channels in Cardiometabolic Diseases and Myocardial Ischemia Reperfusion Injury
Volume: 18 Issue: 15
关键词: 心脏代谢疾病,糖尿病,高血压,心肌缺血再灌注损伤,肥胖,瞬时受体电位通道
摘要: Background: Cardiovascular disease is still the most frequent cause of death in both developed and developing countries while metabolic syndrome and myocardial ischemia reperfusion (I/R) injury are the common risk factors responsible for the impaired cardiac function. Transient receptor potential (TRP) channels are non-selective cation channels, that sense a broad range of stimuli from physical conditions such as stretch, to chemicals including capsaicin.
Objective: The diverse studies have revealed multifunctional roles of TRP channels in the physiological conditions and various diseases while some members of TRP channel superfamily are demonstrated to participate in the pathophysiology of cardiometabolic diseases and myocardial ischemia reperfusion injury. Here we discuss the roles of TRP channels in myocardial ischemia reperfusion and cardiometabolic diseases and their potential use in treating these diseases.
Results: Regulation of TRP channels facilitates the control of metabolic syndrome such as obesity, diabetes mellitus, hypertension, and atherosclerosis. This review presents an overview of our current knowledge regarding the physiological functions of TRP channels in the metabolic and cardiovascular systems and their contributions to cardiometabolic diseases and I/R injury.
Conclusion: On the basis of these discoveries, the therapeutic potential of targeting novel TRP channels can be proposed for the treatment of cardiometabolic diseases and I/R injury.
Export Options
About this article
Cite this article as:
Targeting Transient Receptor Potential Channels in Cardiometabolic Diseases and Myocardial Ischemia Reperfusion Injury, Current Drug Targets 2017; 18 (15) . https://dx.doi.org/10.2174/1389450116666151019102052
DOI https://dx.doi.org/10.2174/1389450116666151019102052 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Stroke Subtypes and their Possible Implication in Stroke Prevention Drug Strategies
Current Vascular Pharmacology Mechanisms of the Beneficial Actions of Ischemic Preconditioning on Subcellular Remodeling in Ischemic-Reperfused Heart
Current Cardiology Reviews Pharmacovigilance and the Cardiovascular System: Two Sides to Every Story
Current Drug Safety Mechanosensitive Channels: Therapeutic Targets in the Myocardium?
Current Pharmaceutical Design SIRT1 as a Promising Novel Therapeutic Target for Myocardial Ischemia Reperfusion Injury and Cardiometabolic Disease
Current Drug Targets Autophagy Inhibition Rescues Against Leptin-Induced Cardiac Contractile Dysfunction
Current Pharmaceutical Design Thrombomodulin Links Coagulation to Inflammation and Immunity
Current Drug Targets The Cardiovascular Nutrapharmacology of Resveratrol: Pharmacokinetics, Molecular Mechanisms and Therapeutic Potential
Current Medicinal Chemistry Hydrogen Sulfide in Inflammation: Friend or Foe?
Inflammation & Allergy - Drug Targets (Discontinued) Mast Cells: Pivotal Players in Cardiovascular Diseases
Current Cardiology Reviews Novel Oral Anticoagulants in the Treatment of Acute Coronary Syndromes: Is there any Room for New Anticoagulants?
Current Clinical Pharmacology Towards Isozyme-Selective HDAC Inhibitors For Interrogating Disease
Current Topics in Medicinal Chemistry Bone Marrow Mesenchymal Stem Cells: Agents of Immunomodulation and Neuroprotection
Current Stem Cell Research & Therapy Recent Advances in Ethnopharmacological and Toxicological Properties of Bioactive Compounds from <i>Aloe barbadensis</i> (Miller), <i>Aloe vera</i>
Current Bioactive Compounds Chromogranin A and the Endothelial Barrier Function
Current Medicinal Chemistry Mechanisms of Esophageal Protection, Gastroprotection and Ulcer Healing by Melatonin. Implications for the Therapeutic use of Melatonin in Gastroesophageal Reflux Disease (GERD) and Peptic Ulcer Disease
Current Pharmaceutical Design Vascular Effects of Estrogenic Menopausal Hormone Therapy
Reviews on Recent Clinical Trials Oxidative Stress: Apoptosis in Neuronal Injury
Current Alzheimer Research Vascular effects of flavonoids
Current Medicinal Chemistry Pharmacological Modulation of Caspase Activation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents